211 related articles for article (PubMed ID: 18511418)
1. Substrate recognition mechanism of VAMP/synaptobrevin-cleaving clostridial neurotoxins.
Sikorra S; Henke T; Galli T; Binz T
J Biol Chem; 2008 Jul; 283(30):21145-52. PubMed ID: 18511418
[TBL] [Abstract][Full Text] [Related]
2. Substrate recognition of VAMP-2 by botulinum neurotoxin B and tetanus neurotoxin.
Chen S; Hall C; Barbieri JT
J Biol Chem; 2008 Jul; 283(30):21153-9. PubMed ID: 18511417
[TBL] [Abstract][Full Text] [Related]
3. Cleavage of members of the synaptobrevin/VAMP family by types D and F botulinal neurotoxins and tetanus toxin.
Yamasaki S; Baumeister A; Binz T; Blasi J; Link E; Cornille F; Roques B; Fykse EM; Südhof TC; Jahn R
J Biol Chem; 1994 Apr; 269(17):12764-72. PubMed ID: 8175689
[TBL] [Abstract][Full Text] [Related]
4. Structural determinants of the specificity for synaptic vesicle-associated membrane protein/synaptobrevin of tetanus and botulinum type B and G neurotoxins.
Pellizzari R; Rossetto O; Lozzi L; Giovedi' S; Johnson E; Shone CC; Montecucco C
J Biol Chem; 1996 Aug; 271(34):20353-8. PubMed ID: 8702770
[TBL] [Abstract][Full Text] [Related]
5. VAMP/synaptobrevin cleavage by tetanus and botulinum neurotoxins is strongly enhanced by acidic liposomes.
Caccin P; Rossetto O; Rigoni M; Johnson E; Schiavo G; Montecucco C
FEBS Lett; 2003 May; 542(1-3):132-6. PubMed ID: 12729912
[TBL] [Abstract][Full Text] [Related]
6. Structural and biochemical studies of botulinum neurotoxin serotype C1 light chain protease: implications for dual substrate specificity.
Jin R; Sikorra S; Stegmann CM; Pich A; Binz T; Brunger AT
Biochemistry; 2007 Sep; 46(37):10685-93. PubMed ID: 17718519
[TBL] [Abstract][Full Text] [Related]
7. Detection of VAMP Proteolysis by Tetanus and Botulinum Neurotoxin Type B In Vivo with a Cleavage-Specific Antibody.
Fabris F; Šoštarić P; Matak I; Binz T; Toffan A; Simonato M; Montecucco C; Pirazzini M; Rossetto O
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457172
[TBL] [Abstract][Full Text] [Related]
8. Identification of the amino acid residues rendering TI-VAMP insensitive toward botulinum neurotoxin B.
Sikorra S; Henke T; Swaminathan S; Galli T; Binz T
J Mol Biol; 2006 Mar; 357(2):574-82. PubMed ID: 16430921
[TBL] [Abstract][Full Text] [Related]
9. Cooperative exosite-dependent cleavage of synaptobrevin by tetanus toxin light chain.
Cornille F; Martin L; Lenoir C; Cussac D; Roques BP; Fournie-Zaluski MC
J Biol Chem; 1997 Feb; 272(6):3459-64. PubMed ID: 9013591
[TBL] [Abstract][Full Text] [Related]
10. Tetanus and botulinum neurotoxins: turning bad guys into good by research.
Rossetto O; Seveso M; Caccin P; Schiavo G; Montecucco C
Toxicon; 2001 Jan; 39(1):27-41. PubMed ID: 10936621
[TBL] [Abstract][Full Text] [Related]
11. Differences in the protease activities of tetanus and botulinum B toxins revealed by the cleavage of vesicle-associated membrane protein and various sized fragments.
Foran P; Shone CC; Dolly JO
Biochemistry; 1994 Dec; 33(51):15365-74. PubMed ID: 7803399
[TBL] [Abstract][Full Text] [Related]
12. Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificity.
Arndt JW; Chai Q; Christian T; Stevens RC
Biochemistry; 2006 Mar; 45(10):3255-62. PubMed ID: 16519520
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of action of tetanus and botulinum neurotoxins.
Montecucco C; Schiavo G
Mol Microbiol; 1994 Jul; 13(1):1-8. PubMed ID: 7527117
[TBL] [Abstract][Full Text] [Related]
14. Structural and biochemical characterization of the protease domain of the mosaic botulinum neurotoxin type HA.
Lam KH; Sikorra S; Weisemann J; Maatsch H; Perry K; Rummel A; Binz T; Jin R
Pathog Dis; 2018 Jun; 76(4):. PubMed ID: 29688327
[TBL] [Abstract][Full Text] [Related]
15. Different VAMP/synaptobrevin complexes for spontaneous and evoked transmitter release at the crayfish neuromuscular junction.
Hua SY; Raciborska DA; Trimble WS; Charlton MP
J Neurophysiol; 1998 Dec; 80(6):3233-46. PubMed ID: 9862918
[TBL] [Abstract][Full Text] [Related]
16. Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, and E: domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage.
Vaidyanathan VV; Yoshino K; Jahnz M; Dörries C; Bade S; Nauenburg S; Niemann H; Binz T
J Neurochem; 1999 Jan; 72(1):327-37. PubMed ID: 9886085
[TBL] [Abstract][Full Text] [Related]
17. Botulinum Neurotoxin F Subtypes Cleaving the VAMP-2 Q
Sikorra S; Skiba M; Dorner MB; Weisemann J; Weil M; Valdezate S; Davletov B; Rummel A; Dorner BG; Binz T
Toxins (Basel); 2018 Aug; 10(8):. PubMed ID: 30071628
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of synaptic neurotransmitter release mechanisms using bacterial toxins].
Doussau F; Humeau Y; Vitiello F; Popoff MR; Poulain B
J Soc Biol; 1999; 193(6):457-67. PubMed ID: 10783704
[TBL] [Abstract][Full Text] [Related]
19. Tetanus and botulinum neurotoxins: mechanism of action and therapeutic uses.
Pellizzari R; Rossetto O; Schiavo G; Montecucco C
Philos Trans R Soc Lond B Biol Sci; 1999 Feb; 354(1381):259-68. PubMed ID: 10212474
[TBL] [Abstract][Full Text] [Related]
20. Enzymatic profiling of tetanus and botulinum neurotoxins based on vesicle-associated-membrane protein derived fluorogenic substrates.
Perpetuo EA; Juliano L; Juliano MA; Fratelli F; Prado SM; Pimenta DC; Lebrun I
Protein Pept Lett; 2008; 15(10):1100-6. PubMed ID: 19075822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
